KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Sales (2016 - 2025)

Historic Return on Sales for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.39%.

  • Gilead Sciences' Return on Sales rose 2300.0% to 0.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% down from last year.
  • Latest data reveals that Gilead Sciences reported Return on Sales of 0.39% as of Q3 2025, which was up 2300.0% from 0.28% recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Return on Sales registered a high of 0.39% during Q3 2025, and its lowest value of 0.62% during Q1 2024.
  • In the last 5 years, Gilead Sciences' Return on Sales had a median value of 0.22% in 2022 and averaged 0.17%.
  • In the last 5 years, Gilead Sciences' Return on Sales skyrocketed by 8900bps in 2021 and then plummeted by -7800bps in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Return on Sales stood at 0.05% in 2021, then skyrocketed by 326bps to 0.22% in 2022, then dropped by -10bps to 0.2% in 2023, then rose by 18bps to 0.24% in 2024, then surged by 67bps to 0.39% in 2025.
  • Its last three reported values are 0.39% in Q3 2025, 0.28% for Q2 2025, and 0.2% during Q1 2025.